|
CN1150433A
(zh)
|
1994-03-30 |
1997-05-21 |
米托科公司 |
线粒体缺陷相关疾病的诊断，治疗以及细胞和动物模型
|
|
US6472378B2
(en)
|
1998-08-31 |
2002-10-29 |
Pro-Neuron, Inc. |
Compositions and methods for treatment of mitochondrial diseases
|
|
JP2002538167A
(ja)
|
1999-03-03 |
2002-11-12 |
バイオジェン インコーポレイテッド |
脂質の代謝および貯蔵を調節する方法
|
|
GB2350565A
(en)
|
1999-05-28 |
2000-12-06 |
Johnson & Johnson Medical Ltd |
Biological wound dressings comprising mitochondria
|
|
DE19937348A1
(de)
|
1999-08-11 |
2001-02-22 |
Aventis Cropscience Gmbh |
Nukleinsäuremoleküle aus Pflanzen codierend Enzyme, die an der Stärkesynthese beteiligt sind
|
|
US6773881B2
(en)
|
2000-03-31 |
2004-08-10 |
The General Hospital Corporation |
Methods of modulating hair growth
|
|
US7238727B2
(en)
|
2000-10-13 |
2007-07-03 |
Chugai Seiyaku Kabushiki Kaisha |
Compositions for improving lipid metabolism
|
|
US20030040475A1
(en)
|
2001-01-16 |
2003-02-27 |
Yasuhiro Toba |
Agents for improving lipid metabolism and reducing high blood pressure
|
|
US7339090B2
(en)
|
2001-02-13 |
2008-03-04 |
Avigenics, Inc. |
Microinjection devices and methods of use
|
|
JP4603192B2
(ja)
|
2001-05-10 |
2010-12-22 |
株式会社カネカ |
毛髪頭皮用組成物
|
|
WO2003012050A2
(en)
|
2001-07-31 |
2003-02-13 |
Northeastern University |
Mitochondrial genome replenishment
|
|
AU2002324645C1
(en)
|
2001-08-08 |
2008-11-06 |
Levesque Biosciences, Inc. |
Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof
|
|
US7138134B2
(en)
|
2001-12-18 |
2006-11-21 |
Arizona Health Consulting Group, Llc |
Preparation and administration of jojoba product for reducing weight, fat and blood lipid levels
|
|
US20050153381A1
(en)
|
2002-02-14 |
2005-07-14 |
Marusich Michael F. |
Immunocapture of mitochondrial protein complexes
|
|
AU2004238375A1
(en)
|
2003-05-13 |
2004-11-25 |
The Regents Of The University Of Colorado |
Diagnostic and therapeutic treatments related to mitochondrial disorders
|
|
CA2526493A1
(en)
|
2003-05-22 |
2004-12-02 |
Theraptosis S.A. |
Means for preventing and treating cellular death and their biological applications
|
|
US7407800B1
(en)
|
2003-09-19 |
2008-08-05 |
Pierce Biotechnology, Inc. |
Method for the isolation of intact mitochondria from cells
|
|
EP1709084A4
(en)
|
2003-12-23 |
2008-05-28 |
Nono Inc |
POLYPEPTIDES FOR MODULATING BINDING OF TRP-CHANNEL PROTEINS AND TRP-ASSOCIATED PROTEINS
|
|
US20060024277A1
(en)
|
2004-07-27 |
2006-02-02 |
Sivak Hannah N |
Method of skin care and/or treatment using extracts enriched in mitochondria
|
|
JP2006131600A
(ja)
|
2004-11-09 |
2006-05-25 |
R & D Cell-Science Optional Medico:Kk |
発毛促進のためのヒト細胞組成物
|
|
US20100047270A1
(en)
|
2005-06-10 |
2010-02-25 |
Albertsson Per-Aake |
Use of plant cell membrane for the treatment of obesity
|
|
AU2012201710B2
(en)
|
2006-05-11 |
2014-01-16 |
Regenics As |
Administration of cells and cellular extracts for rejuvenation
|
|
AT502353B1
(de)
|
2006-06-29 |
2007-07-15 |
Avl List Gmbh |
Verfahren und vorrichtung zur konditionierung eines o2-hältigen gases
|
|
EP2150117A4
(en)
*
|
2007-05-02 |
2011-10-05 |
Mclean Hospital Corp |
METHODS AND COMPOSITIONS FOR MITOCHONDRIA REPLACEMENT THERAPY
|
|
WO2008152640A2
(en)
|
2007-06-13 |
2008-12-18 |
Pluristem Ltd. |
Three dimensional biocompatible scaffolds for ex-vivo expansion and transplantation of stem cells
|
|
EP3029061B1
(en)
|
2008-06-18 |
2017-09-13 |
The Texas A&M University System |
Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage
|
|
WO2011059547A2
(en)
|
2009-10-30 |
2011-05-19 |
Xenotech, Llc |
Cryopreservation of cells and subcellular fractions
|
|
US8846028B2
(en)
|
2010-10-28 |
2014-09-30 |
The Invention Science Fund I, Llc |
Mitochondrial enhancement of cells
|
|
JP6030067B2
(ja)
|
2010-12-03 |
2016-11-24 |
アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ |
薬学的クリーム組成物および使用法
|
|
JP6054301B2
(ja)
|
2010-12-23 |
2017-01-11 |
アマゼンティス エスアーＡｍａｚｅｎｔｉｓ Ｓａ |
ミトコンドリア機能向上と、神経変性疾患および認知障害治療とのための組成物および方法
|
|
CA2847292A1
(en)
|
2011-06-29 |
2013-01-03 |
The General Hospital Corporation |
Compositions and methods for enhancing bioenergetic status in female germ cells
|
|
US20130022666A1
(en)
|
2011-07-20 |
2013-01-24 |
Anna Brzezinska |
Methods and compositions for transfer of mitochondria into mammalian cells
|
|
CN102266350A
(zh)
|
2011-07-20 |
2011-12-07 |
黄必录 |
逆转干细胞衰老的方案
|
|
CN102293178A
(zh)
|
2011-08-28 |
2011-12-28 |
黄必录 |
使个体去衰老的方法
|
|
EP2741757B1
(en)
|
2011-09-11 |
2018-05-16 |
Minovia Therapeutics Ltd. |
Compositions of functional mitochondria and uses thereof
|
|
EP3785767A1
(en)
|
2011-12-02 |
2021-03-03 |
Fate Therapeutics, Inc. |
Enhanced stem cell composition
|
|
US8648034B2
(en)
|
2011-12-09 |
2014-02-11 |
Changhua Christian Hospital |
Method and applications of peptide-mediated mitochondrial delivery system
|
|
WO2013149064A1
(en)
|
2012-03-30 |
2013-10-03 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Uridine diphosphate compounds as mobilizers of hematopoietic progenitor cells
|
|
US10702556B2
(en)
|
2012-05-16 |
2020-07-07 |
Minovia Therpautices Ltd. |
Compositions and methods for inducing angiogenesis
|
|
EP3459522B1
(en)
|
2012-12-10 |
2021-02-17 |
Regenics AS |
Use of egg cellular extracts for wound treatment
|
|
WO2014130518A1
(en)
|
2013-02-19 |
2014-08-28 |
Children's Medical Center Corporation |
Abcb5(+) stem cells for treating ocular disease
|
|
DE102013225588A1
(de)
|
2013-12-11 |
2014-04-17 |
Henkel Ag & Co. Kgaa |
Verwendung und Mittel zur Verbesserung der Haarstruktur
|
|
JP2017505819A
(ja)
|
2014-02-04 |
2017-02-23 |
カイト ファーマ インコーポレイテッドＫｉｔｅ Ｐｈａｒｍａ， Ｉｎｃ |
Ｂ細胞悪性腫瘍及び他のがんの治療に有用な自己ｔ細胞を産生する方法、並びにその組成物
|
|
EP2918458B1
(en)
|
2014-03-11 |
2016-12-07 |
Autoliv Development AB |
A vehicle braking arrangement
|
|
WO2015142855A1
(en)
|
2014-03-17 |
2015-09-24 |
University Of Virginia Patent Foundation |
Compositions and methods for treating retinopathy
|
|
CN103976935A
(zh)
|
2014-05-28 |
2014-08-13 |
广州市白云区天芳化妆品厂 |
一种抗衰原液及其制备方法
|
|
AU2015289644A1
(en)
|
2014-07-15 |
2017-02-02 |
Juno Therapeutics, Inc. |
Engineered cells for adoptive cell therapy
|
|
WO2016008937A1
(en)
*
|
2014-07-16 |
2016-01-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the intercellular transfer of isolated mitochondria in recipient cells
|
|
CN106795490B
(zh)
|
2014-09-11 |
2021-01-19 |
台湾粒线体应用技术股份有限公司 |
用线粒体特化细胞治疗神经退行性疾病的医药组合物
|
|
JP6441472B2
(ja)
|
2014-09-30 |
2018-12-19 |
台灣粒線體應用技術股▲扮▼有限公司Ｔａｉｗａｎ Ｍｉｔｏｃｈｏｎｄｒｉｏｎ Ａｐｐｌｉｅｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏ．，Ｌｔｄ． |
活性成分として外因性ミトコンドリアを含む組成物、ならびにその使用およびそのための細胞修復法
|
|
US20170327791A1
(en)
|
2014-11-14 |
2017-11-16 |
Jcr Pharmaceuticals Co., Ltd |
Muscular dystrophy therapeutic agent containing pluripotent stem cells derived from dental pulp
|
|
GB201500427D0
(en)
|
2015-01-12 |
2015-02-25 |
Isis Innovation |
Method
|
|
EP3244735A4
(en)
|
2015-01-14 |
2018-07-04 |
Calix Ltd |
Improved pathogen inhibitor
|
|
IL299482B2
(en)
*
|
2015-02-26 |
2025-02-01 |
Minovia Therapeutics Ltd |
Mammalian cells are enriched with active mitochondria
|
|
US10537594B2
(en)
|
2015-02-27 |
2020-01-21 |
University Of Connecticut |
Targeted transplantation of mitochondria to hepatocytes
|
|
CA2987064A1
(en)
|
2015-05-28 |
2016-12-01 |
Celularity Inc. |
Placental-derived stem cells and uses thereof to restore the regenerative engine, correct proteomic defects and extend lifespan of aging subjects
|
|
US11903974B2
(en)
|
2015-11-30 |
2024-02-20 |
Flagship Pioneering Innovations V, Inc. |
Methods and compositions relating to chondrisomes from cultured cells
|
|
SI4272834T1
(sl)
|
2016-01-15 |
2026-03-31 |
Beth Israel Deaconess Medical Center, Inc. |
Terapevtska uporaba mitohondrijev in kombiniranih mitohondrijskih sredstev
|
|
MX2019005127A
(es)
|
2016-11-03 |
2019-09-26 |
Exostem Biotec Ltd |
Poblaciones y productos de células madre mesenquimales y sus usos.
|
|
WO2018088874A1
(ko)
|
2016-11-14 |
2018-05-17 |
주식회사 파이안바이오테크놀로지 |
외래 미토콘드리아를 세포로 전달하는 방법
|
|
EP3549589A4
(en)
|
2016-11-30 |
2020-07-15 |
Paean Biotechnology Inc. |
PHARMACEUTICAL COMPOSITION CONTAINING MITOCHONDRIA
|
|
US20200023005A1
(en)
|
2017-03-26 |
2020-01-23 |
Minovia Therapeutics Ltd. |
Mitochondrial compositions and methods for treatment of skin and hair
|
|
CN112601532A
(zh)
|
2018-07-22 |
2021-04-02 |
米诺维亚疗法有限公司 |
使用富集有功能性线粒体的干细胞的线粒体增强疗法
|
|
JP2021531288A
(ja)
|
2018-07-22 |
2021-11-18 |
ミノヴィア セラピューティクス リミテッド |
眼疾患のミトコンドリア増強療法
|
|
WO2020021536A1
(en)
|
2018-07-22 |
2020-01-30 |
Minovia Therapeutics Ltd. |
Mitochondrial augmentation therapy for primary mitochondrial diseases
|
|
JP7524157B2
(ja)
|
2018-07-22 |
2024-07-29 |
ミノヴィア セラピューティクス リミテッド |
脳疾患のミトコンドリア増強療法
|
|
JP2021532095A
(ja)
|
2018-07-22 |
2021-11-25 |
ミノヴィア セラピューティクス リミテッド |
肝臓疾患のミトコンドリア増強療法
|
|
US12551504B2
(en)
|
2018-07-22 |
2026-02-17 |
Minovia Therapeutics Ltd. |
Mitochondrial augmentation therapy of pancreatic diseases
|
|
JP7458368B2
(ja)
|
2018-07-22 |
2024-03-29 |
ミノヴィア セラピューティクス リミテッド |
筋疾患のミトコンドリア増強療法
|
|
EP3837359A4
(en)
|
2018-08-14 |
2022-05-11 |
Imel Biotherapeutics, Inc. |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES OR DISORDERS AND HETEROPLASMIA
|
|
WO2020223576A1
(en)
|
2019-04-30 |
2020-11-05 |
Chondrial Therapeutics, Inc. |
Frataxin-sensitive markers for determining effectiveness of frataxin replacement therapy
|
|
WO2021199032A1
(en)
|
2020-03-31 |
2021-10-07 |
Minovia Therapeutics Ltd. |
Mitochondrial augmentation therapy
|
|
CA3172402A1
(en)
|
2020-03-31 |
2021-10-07 |
Minovia Therapeutics Ltd. |
Mitochondria-enriched genetically engineered cells and uses thereof
|